Skip to main content
Caplight Logo









AURIMOD GmbH

AURIMOD GmbH

Private
ViennaHealthcare & Life Scienceshttps://aurimod.com/

Last Round

Grant

Oct 1, 2019

Total Funding Raised

$2.43M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AURIMOD GmbH is a medical technology company that develops wearable neuromodulation devices for the personalized, non-pharmacological treatment of chronic pain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

neuromodulationauricular vagus nerve stimulationaVNSvagus nerve stimulatormedical wearablepain managementchronic pain treatmentmedtechdigital healthnon-pharmacological pain reliefpain diarybioelectronic medicinedigital biomarkertherapy optimizationwearable tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AURIMOD GmbH Comparables

Compare AURIMOD GmbH with similar companies based on industry and business-model similarity.

AURIMOD GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Soterix Medical
79%
Parasym
79%
JBA Health
76%

AURIMOD GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2019

Key People

Founding team and executive leadership

Stefan Kampusch

Chief Executive Officer

Executive Team

Bernhard Fabian

Chief Operating Officer, Head of QM & RA, PRRC

Executive Team

AURIMOD GmbH Investors

Notable investors and investment history

AURIMOD GmbH investors
InvestorRounds
ILUM TecEarly Funding
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 439% MoM, from 241 to 1.3K.

  • Nov 16, 2025

    Grew 31% QoQ, from 13 to 17 employees.

AURIMOD GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AURIMOD GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AURIMOD GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna
Employee Range13
Year Founded2015
Last FundingOct 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?